Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Curtis Cooper & David Mackie. (2011) Hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine: a review of HEPLISAV™ safety and efficacy. Expert Review of Vaccines 10:4, pages 417-427.
Read now
Read now
Articles from other publishers (43)
Yadan Zhang, Rong Yang, Guangying Yuan, Weidong Li, Zihao Cui, Zhuangzhuang Xiao, Xiaofei Dong, Hongqiang Yang, Xiaojuan Liu, Le Zhang, Yirong Hou, Manyu Liu, Sushi Liu, Yu Hao, Yuntao Zhang & Xiaotong Zheng. (2023) Enhancing Inactivated Yellow Fever 17D Vaccine-Induced Immune Responses in Balb/C Mice Using Alum/CpG. Vaccines 11:12, pages 1744.
Crossref
Crossref
Boyang Yu, Boye Li, Tian Chen, Jinning Yang, Xiaoli Wang, Bo Peng & Qin Hu. (2022) A NF-κB-Based High-Throughput Screening for Immune Adjuvants and Inhibitors. Inflammation 46:2, pages 598-611.
Crossref
Crossref
David B. Weiner, Kathrin Jansen & Tonya Villafana. 2023. Plotkin's Vaccines. Plotkin's Vaccines
1374
1396.e11
.
Abhishek Singh Rathore, Animesh Sarker & Rinkoo Devi Gupta. (2020) Production and immunogenicity of Fubc subunit protein redesigned from DENV envelope protein. Applied Microbiology and Biotechnology 104:10, pages 4333-4344.
Crossref
Crossref
Saibal Das, Kirubakaran Ramakrishnan, Sapan Kumar Behera, Mahalakshmi Ganesapandian, Alphienes Stanley Xavier & Sandhiya Selvarajan. (2019) Hepatitis B Vaccine and Immunoglobulin: Key Concepts. Journal of Clinical and Translational Hepatology 7:X, pages 1-7.
Crossref
Crossref
Jie Zeng, Wenhao Fu, Zhenping Qi, Qiushuang Zhu, Huawei He, Chengzhi Huang, Hua Zuo & Chengde Mao. (2019) Self‐Assembly of Microparticles by Supramolecular Homopolymerization of One Component DNA Molecule. Small 15:26, pages 1805552.
Crossref
Crossref
Medea Neek, Tae Il Kim & Szu-Wen Wang. (2019) Protein-based nanoparticles in cancer vaccine development. Nanomedicine: Nanotechnology, Biology and Medicine 15:1, pages 164-174.
Crossref
Crossref
Mohana Rajakulendran, Elizabeth Huiwen ThamJian Yi SohHP Van Bever. (2018) Novel strategies in immunotherapy for allergic diseases. Asia Pacific Allergy 8:2.
Crossref
Crossref
David B. Weiner & Gary J. Nabel. 2018. Plotkin's Vaccines. Plotkin's Vaccines
1305
1319.e8
.
Mona O. Mohsen, Ariane C. Gomes, Gustavo Cabral-Miranda, Caroline C. Krueger, Fabiana MS Leoratti, Jens V. Stein & Martin F. Bachmann. (2017) Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination. Journal of Controlled Release 251, pages 92-100.
Crossref
Crossref
John D. Campbell. 2017. Vaccine Adjuvants. Vaccine Adjuvants
15
27
.
Anna U. Bielinska, Jessica J. O’Konek, Katarzyna W. Janczak & James R. BakerJr.Jr.. (2016) Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant. Vaccine 34:34, pages 4017-4024.
Crossref
Crossref
Bob Milley, Radwan Kiwan, Gary S. Ott, Carlo Calacsan, Melissa Kachura, John D. Campbell, Holger Kanzler & Robert L. Coffman. (2016) Optimization, Production, and Characterization of a CpG-Oligonucleotide-Ficoll Conjugate Nanoparticle Adjuvant for Enhanced Immunogenicity of Anthrax Protective Antigen. Bioconjugate Chemistry 27:5, pages 1293-1304.
Crossref
Crossref
Fred Zepp. 2016. Vaccine Design. Vaccine Design
57
84
.
A. Kreiss, G.K. Brown, C. Tovar, A.B. Lyons & G.M. Woods. (2015) Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations. Vaccine 33:26, pages 3016-3025.
Crossref
Crossref
Emily P. Wen, Ronald Ellis & Narahari S. PujarKarl Melber, Volker Jenzelewski, Roland Weyhenmeyer & Zbigniew Janowicz. 2014. Vaccine Development and Manufacturing. Vaccine Development and Manufacturing
51
80
.
Diane G. Elliott, Gregory D. Wiens, K. Larry Hammell & Linda D. Rhodes. 2014. Fish Vaccination. Fish Vaccination
255
272
.
Juergen Mairhofer & Alvaro R. Lara. 2014. Cancer Vaccines. Cancer Vaccines
505
541
.
Ross W. Lindsay, Ian Ouellette, Heather E. Arendt, Jennifer Martinez, Joanne DeStefano, Mary Lopez, George N. Pavlakis, Maria J. Chiuchiolo, Christopher L. Parks & C. Richter King. (2013) SIV antigen-specific effects on immune responses induced by vaccination with DNA electroporation and plasmid IL-12. Vaccine 31:42, pages 4749-4758.
Crossref
Crossref
Pedro H. Oliveira & Juergen Mairhofer. (2013) Marker-free plasmids for biotechnological applications – implications and perspectives. Trends in Biotechnology 31:9, pages 539-547.
Crossref
Crossref
Juergen Mairhofer & Reingard Grabherr. 2013. Minicircle and Miniplasmid DNA Vectors. Minicircle and Miniplasmid DNA Vectors
23
36
.
David B. Weiner & Gary J. Nabel. 2013. Vaccines. Vaccines
1232
1242
.
Amit K. Goyal, Goutam Rath & Tarun Garg. 2013. DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases. DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases
67
120
.
Wai-Kay Seto, James Fung, Man-Fung Yuen & Ching-Lung Lai. (2012) Future Prevention and Treatment of Chronic Hepatitis B Infection. Journal of Clinical Gastroenterology 46:9, pages 725-734.
Crossref
Crossref
Alan Gunn & Sarah J. Pitt. 2012. Parasitology. Parasitology
375
429
.
Gerd Lipowsky & Martin F. Bachmann. 2011. Development of Vaccines. Development of Vaccines
19
63
.
Geert Leroux-Roels. (2010) Unmet needs in modern vaccinology. Vaccine 28, pages C25-C36.
Crossref
Crossref
Fred Zepp. (2010) Principles of vaccine design—Lessons from nature. Vaccine 28, pages C14-C24.
Crossref
Crossref
Florence Bayard, Silvina Malmassari, Qiang Deng, Yu-Chun Lone & Marie-Louise Michel. (2010) Hepatitis B virus (HBV)-derived DRB1*0101-restricted CD4 T-cell epitopes help in the development of HBV-specific CD8+ T cells in vivo. Vaccine 28:22, pages 3818-3826.
Crossref
Crossref
Ayman Al-Mariri. (2010) Protection of BALB/c mice against Brucella melitensis 16M infection induced by vaccination with live Escherchia coli expression Brucella P39 protein. Vaccine 28:7, pages 1766-1770.
Crossref
Crossref
Penelope Koraka, Byron E. E. Martina & Albert D. M. E. Osterhaus. (2010) Bioinformatics in New Generation Flavivirus Vaccines. Journal of Biomedicine and Biotechnology 2010, pages 1-17.
Crossref
Crossref
Yan Zhi & Guangping Gao. 2010. Muscle Gene Therapy. Muscle Gene Therapy
231
247
.
Reto Crameri, Thomas M Kündig & Cezmi A Akdis. (2009) Modular antigen-translocation as a novel vaccine strategy for allergen-specific immunotherapy. Current Opinion in Allergy & Clinical Immunology 9:6, pages 568-573.
Crossref
Crossref
Jayalakshmi Krishnan, Gwang Lee & Sangdun Choi. (2009) Drugs targeting toll-like receptors. Archives of Pharmacal Research 32:11.
Crossref
Crossref
R. N. COLER, D. CARTER, M. FRIEDE & S. G. REED. (2009) Adjuvants for malaria vaccines. Parasite Immunology 31:9, pages 520-528.
Crossref
Crossref
Katsuyuki Takeda, Steven W. Dow, Nobuaki Miyahara, Taku Kodama, Toshiyuki Koya, Christian Taube, Anthony Joetham, Jung-Won Park, Azzeddine Dakhama, Ross M. Kedl & Erwin W. Gelfand. (2009) Vaccine-Induced CD8+ T Cell-Dependent Suppression of Airway Hyperresponsiveness and Inflammation. The Journal of Immunology 183:1, pages 181-190.
Crossref
Crossref
W. R. Thomas. (2009) Innovation in immunotherapy. Clinical & Experimental Allergy 39:4, pages 450-454.
Crossref
Crossref
Srinivas Garlapati, Marina Facci, Monika Polewicz, Stacy Strom, Lorne A. Babiuk, George Mutwiri, Robert E.W. Hancock, Melissa R. Elliott & Volker Gerdts. (2009) Strategies to link innate and adaptive immunity when designing vaccine adjuvants. Veterinary Immunology and Immunopathology 128:1-3, pages 184-191.
Crossref
Crossref
Tsan Xiao. (2008) Innate immune recognition of nucleic acids. Immunologic Research 43:1-3, pages 98-108.
Crossref
Crossref
David N. Nguyen, Jordan J. Green, Juliana M. Chan, Robert Langer & Daniel G. Anderson. (2009) Polymeric Materials for Gene Delivery and DNA Vaccination. Advanced Materials 21:8, pages 847-867.
Crossref
Crossref
C. Guiducci, R. L. Coffman & F. J. Barrat. (2009) Signalling pathways leading to IFN-α production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications. Journal of Internal Medicine 265:1, pages 43-57.
Crossref
Crossref
Steven G. Reed, Sylvie Bertholet, Rhea N. Coler & Martin Friede. (2009) New horizons in adjuvants for vaccine development. Trends in Immunology 30:1, pages 23-32.
Crossref
Crossref
Michele A. Kutzler & David B. Weiner. (2008) DNA vaccines: ready for prime time?. Nature Reviews Genetics 9:10, pages 776-788.
Crossref
Crossref